Thalassemia Major

• FDA approval · 2020-04-13
  FDA Approved: DEFERASIROX — Supplemental Application (Xiromed, LLC)

  The FDA approved a supplemental application for deferasirox filed by Xiromed, LLC under an ANDA.

• FDA approval · 2015-09-09
  FDA Approved: FERRIPROX — Original Application (Chiesi USA, Inc.)

  The FDA granted approval for Ferriprox (deferiprone) to treat iron overload under an original NDA filed by Chiesi USA, Inc.

• FDA approval · 2012-06-20
  FDA Approved: DEFEROXAMINE — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for Deferoxamine Mesylate (Deferoxamine) from Fresenius Kabi USA, LLC.